The University of North Carolina at Chapel Hill

Chapel Hill, North Carolina 27599-8700

19 studies enrolling now · 129 studies all time

What they study most

ACL Tear, AIDS, AML, Acid Reflux Disease, Acute Coronary Syndrome, Advanced Cancer, Advanced Malignancies, Alopecia Areata, Alzheimer's Disease, Anemia, Aortic Stenosis, Atopic Dermatitis

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
• A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer — Recruiting now
• Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells — Recruiting now
• A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation — Recruiting now
• Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP) — Recruiting now
• Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis — Recruiting now
• Rett Syndrome Registry — Recruiting now
• Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease — Recruiting now
• Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations — Recruiting now
• RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE — Recruiting now
• Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC — Recruiting now
• Sugary Drink Labeling Study — Recruiting now
• REAL-Fam Feasibility Study for Youth Diabetes Management — Recruiting now
• A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF — Recruiting now
• Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation — Recruiting now
• Preventing Injured Knees From osteoArthritis: Severity Outcomes — Recruiting now
• Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma — Running, not enrolling
• A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer — Running, not enrolling
• A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) — Completed
• Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors — Running, not enrolling
• Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) — Running, not enrolling
• Ascertaining Longterm Outcomes of Fibroid Treatments — Running, not enrolling
• Impact of Standing Orders Optimization — Running, not enrolling
• A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata — Completed
• Fecal Incontinence Treatment (FIT) Study — Completed
• Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery — Completed
• Engaging Clinical Champions to Improve HPV Vaccination — Completed
• First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC) — Running, not enrolling
• A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity — Completed
• A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO) — Enrolling by invitation
• The HARMONY Study: A Intervention to Reduce Cardiometabolic Risk in African American Women — Completed
• A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis — Completed
• Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) — Completed
• Neuroendocrine Tumors - Patient Reported Outcomes — Running, not enrolling
• Promoting Stretching Exercise to Reduce Cardiovascular Health Risk in Late Pregnant Women With Obesity — Completed
• Testing Implementation Strategies to Support Clinic Fidelity to an Outpatient Hypertension Bundle — Enrolling by invitation
• Study of Posterior Cervical Stabilization System (PCSS) as Part of Circumferential Fusion to Treat Multilevel DDD — Running, not enrolling
• Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease — Running, not enrolling
• A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors) — Completed
• Supporting Tailored And Responsive PrEP in Rural North Carolina — Completed
• Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic Malignancies — Completed
• CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) — Running, not enrolling
• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
• This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer — Completed
• Promoting Shared Decision Making for Severe Aortic Stenosis — Enrolling by invitation
• This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year — Stopped early
• Metformin for the Treatment of Endometrial Hyperplasia — Completed
• The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension — Running, not enrolling
• Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC) — Completed